Profound Medical Corp. (PRN.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 237.11M |
| Enterprise Value | 182.2M |
| P/E Ratio | -8.22 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 11.75 |
| Price/Book Ratio | 6.5 |
| Enterprise/Revenue | 10.65 |
| Enterprise/EBITDA | -7.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -1.37 |
| Operating Margin | -1.44 |
AD
Management Effectiveness
| Return On Assets | -0.55 |
| Return On Equity | -0.59 |
Income Statement
| Revenue | 16.38M |
| Revenue/Share | 0.64 |
| Gross Profit | 11.59M |
| EBITDA | -41.41M |
| Net Income | -43.32M |
| Diluted EPS | -1.43 |
Balance Sheet
| Total Cash | 33.34M |
| Total Cash/Share | 0.91 |
| Total Debt | 7.36M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 4.54 |
| Book Value Per Share | 1.16 |
Price History
| 52-Week Change | 19.01 |
| 52-Week High | 12.4 |
| 52-Week Low | 6.52 |
| Moving Average 50 Days | 8.79 |
| Moving Average 200 Days | 9.23 |
Statistics
| Average Volume | 15,530 |
| Shares Outstanding | 36.63M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 16, 2019 |
AD
